Categories : Anti-Infectives
Product Packaging : 10 / 30 capsules
Product Composition : 500 mg
Send MessageGenliva Wellness LLP develops Lincomycin Capsules for bacterial infections caused by susceptible gram-positive organisms affecting the respiratory tract, bones, joints, and soft tissues. The formulation is commonly prescribed in tonsillitis, pneumonia, osteomyelitis, skin infections, and bacterial conditions requiring lincosamide antibacterial therapy.
Lincomycin inhibits bacterial protein synthesis, restricting bacterial growth and multiplication within infected tissues. The medicine is frequently incorporated into antibacterial treatment protocols targeting gram-positive bacterial pathogens and anaerobic bacterial organisms.
Genliva Wellness LLP specializes in oral lincosamide antibiotic manufacturing in Gujarat supplying antibacterial capsule formulations for pharmaceutical distributors, institutional buyers, private labeling companies, and international export markets.
Lincomycin Capsules are formulated for gram-positive antibacterial therapy.
This formulation is prescribed in gram-positive bacterial infection management.
Lincomycin Capsules deliver lincosamide antibacterial therapy for gram-positive infections.